Intranasal administration of peptide hormones: factors affecting transmucosal absorption.
Pontiroli
A E
AE
Cattedra di Clinica Medica, Università di Milano, Italy.
Pozza
G
G
D000281:Administration, Intranasal; D003346:Corticotropin-Releasing Hormone / Q000008:administration & dosage; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D005934:Glucagon / Q000008:administration & dosage / Q000627:therapeutic use; D013007:Growth Hormone-Releasing Hormone / Q000008:administration & dosage; D006728:Hormones / Q000008:administration & dosage*; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use; D010455:Peptides / Q000008:administration & dosage*
D006728:Hormones; D007328:Insulin; D010455:Peptides; D005934:Glucagon; D003346:Corticotropin-Releasing Hormone; D013007:Growth Hormone-Releasing Hormone